Toward Patient-Centered Drug Development in Oncology

Toward Patient-Centered Drug Development in Oncology

Not CLL specific but interesting...from the NEJM

Quote...

'As an oncologist, when I sit with patients to discuss starting a new chemotherapy regimen, their first questions are often “How will it make me feel?” and “How did patients like me feel with this treatment?” Regrettably, this information is generally missing from U.S. drug labels and from published reports of clinical trials — the two information sources most commonly available to people trying to understand the clinical effects of cancer drugs.'

....

Cancer-drug labels stand in sharp contrast to labels for other types of drugs, about 25% of which list the drugs' effects on patients' symptoms or functioning.1 That disparity is surprising, given how common symptoms and functional impairment are in patients with cancer and how toxic oncology drugs can be.

End Quote...

nejm.org/doi/full/10.1056/N...

Last edited by

1 Reply

oldestnewest

You may also like...